WO2001070176A3 - Verwendung von 3,4-dihydroxymandelsäure zum schutz vor ultraviolettlicht-induzierten oxidativen schädigungen - Google Patents

Verwendung von 3,4-dihydroxymandelsäure zum schutz vor ultraviolettlicht-induzierten oxidativen schädigungen Download PDF

Info

Publication number
WO2001070176A3
WO2001070176A3 PCT/EP2001/002546 EP0102546W WO0170176A3 WO 2001070176 A3 WO2001070176 A3 WO 2001070176A3 EP 0102546 W EP0102546 W EP 0102546W WO 0170176 A3 WO0170176 A3 WO 0170176A3
Authority
WO
WIPO (PCT)
Prior art keywords
dihydroxy
ultra
damage caused
mandelic acid
violet light
Prior art date
Application number
PCT/EP2001/002546
Other languages
English (en)
French (fr)
Other versions
WO2001070176A2 (de
Inventor
Jakob Peter Ley
Roland Langner
William Johncock
Original Assignee
Haarmann & Reimer Gmbh
Jakob Peter Ley
Roland Langner
William Johncock
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Haarmann & Reimer Gmbh, Jakob Peter Ley, Roland Langner, William Johncock filed Critical Haarmann & Reimer Gmbh
Priority to AU2001250368A priority Critical patent/AU2001250368A1/en
Priority to JP2001568374A priority patent/JP2003528831A/ja
Priority to EP01923646A priority patent/EP1267822A2/de
Publication of WO2001070176A2 publication Critical patent/WO2001070176A2/de
Publication of WO2001070176A3 publication Critical patent/WO2001070176A3/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L3/00—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs
    • A23L3/34—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by treatment with chemicals
    • A23L3/3454—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by treatment with chemicals in the form of liquids or solids
    • A23L3/3463—Organic compounds; Microorganisms; Enzymes
    • A23L3/3481—Organic compounds containing oxygen
    • A23L3/3508—Organic compounds containing oxygen containing carboxyl groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/52—Stabilizers
    • A61K2800/522—Antioxidants; Radical scavengers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Food Science & Technology (AREA)
  • Toxicology (AREA)
  • Emergency Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Microbiology (AREA)
  • Nutrition Science (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • General Preparation And Processing Of Foods (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Die Erfindung betrifft die Verwendung von 3,4-Dihydroxymandelsäure als Antioxidans und/oder Radikalfänger zum Schutz der Haut, insbesondere der menschlichen Haut, vor Ultraviolettlicht-induzierten oxidativen Schädigungen sowie zum Schutz von kosmetischen oder pharmazeutischen Zubereitungen, anderen Gegenständen und von Nahrungsmitteln gegen Oxidation und/oder Photooxidation.
PCT/EP2001/002546 2000-03-18 2001-03-07 Verwendung von 3,4-dihydroxymandelsäure zum schutz vor ultraviolettlicht-induzierten oxidativen schädigungen WO2001070176A2 (de)

Priority Applications (3)

Application Number Priority Date Filing Date Title
AU2001250368A AU2001250368A1 (en) 2000-03-18 2001-03-07 Use of 3,4-dihydroxy-mandelic acid for protecting against oxidative damage caused by ultra-violet light
JP2001568374A JP2003528831A (ja) 2000-03-18 2001-03-07 紫外光により引き起こされる酸化的損傷に対して保護するための３，４−ジヒドロキシマンデル酸の使用
EP01923646A EP1267822A2 (de) 2000-03-18 2001-03-07 Verwendung von 3,4-dihydroxymandelsäure zum schutz vor ultraviolettlicht-induzierten oxidativen schädigungen

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10013578A DE10013578A1 (de) 2000-03-18 2000-03-18 Verwendung von 3,4-Dihydroxymandelsäure zum Schutz vor Ultraviolettlicht-induzierten oxidativen Schädigungen
DE10013578.1 2000-03-18

Publications (2)

Publication Number Publication Date
WO2001070176A2 WO2001070176A2 (de) 2001-09-27
WO2001070176A3 true WO2001070176A3 (de) 2002-03-07

Family

ID=7635491

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2001/002546 WO2001070176A2 (de) 2000-03-18 2001-03-07 Verwendung von 3,4-dihydroxymandelsäure zum schutz vor ultraviolettlicht-induzierten oxidativen schädigungen

Country Status (7)

Country Link
US (1) US20030053967A1 (de)
EP (1) EP1267822A2 (de)
JP (1) JP2003528831A (de)
CN (1) CN1418087A (de)
AU (1) AU2001250368A1 (de)
DE (1) DE10013578A1 (de)
WO (1) WO2001070176A2 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1864963A1 (de) * 2006-06-02 2007-12-12 DSMIP Assets B.V. Hydroxy-aromatischer Verbindungen, ein Verfahren zur deren Herstellung und ihre Verwendung als Antioxidantien
CN105078775A (zh) * 2014-05-15 2015-11-25 谢铭峻 杏仁酸在抗氧化中的用途

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS548731A (en) * 1977-06-18 1979-01-23 Sunstar Inc Hair dyeing agent
JPS54132243A (en) * 1978-04-04 1979-10-15 Sunstar Inc Skin coloring composition
EP0031561A2 (de) * 1979-12-20 1981-07-08 Merck & Co. Inc. Rektal verabreichbares Zäpfchen, das einen Wirkstoff und einen Hilfsstoff enthält
EP0508324A2 (de) * 1991-04-10 1992-10-14 Ruey J. Dr. Yu 2-Hydroxycarbonsäure oder deren Derivate enthaltende Zusammensetzung und Methode zur Linderung von dermatologischen Alterserscheinungen
US5554652A (en) * 1986-12-23 1996-09-10 Tristrata Inc Method of treating wrinkles using alpha hydroxyacids, alpha ketoacids and a sunscreen agent
EP0770399A2 (de) * 1986-12-23 1997-05-02 Eugene J. Dr. Van Scott Additive zur Verbesserung der topischen Aktivitäten von therapeutischen Mitteln
US5961999A (en) * 1995-06-08 1999-10-05 Wella Aktiengesellschaft Method of skin care using a skin care preparation containing a betaine ester and an α-hydroxy acid

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL126076A (en) * 1998-09-04 2005-05-17 Ibr Ltd Transparent composition comprising phytoene and phytofluene
EP1029849A1 (de) * 1999-02-19 2000-08-23 Haarmann & Reimer Gmbh Hydroxymandelsäureamide phenolischer Amine

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS548731A (en) * 1977-06-18 1979-01-23 Sunstar Inc Hair dyeing agent
JPS54132243A (en) * 1978-04-04 1979-10-15 Sunstar Inc Skin coloring composition
EP0031561A2 (de) * 1979-12-20 1981-07-08 Merck & Co. Inc. Rektal verabreichbares Zäpfchen, das einen Wirkstoff und einen Hilfsstoff enthält
US5554652A (en) * 1986-12-23 1996-09-10 Tristrata Inc Method of treating wrinkles using alpha hydroxyacids, alpha ketoacids and a sunscreen agent
EP0770399A2 (de) * 1986-12-23 1997-05-02 Eugene J. Dr. Van Scott Additive zur Verbesserung der topischen Aktivitäten von therapeutischen Mitteln
EP0508324A2 (de) * 1991-04-10 1992-10-14 Ruey J. Dr. Yu 2-Hydroxycarbonsäure oder deren Derivate enthaltende Zusammensetzung und Methode zur Linderung von dermatologischen Alterserscheinungen
US5961999A (en) * 1995-06-08 1999-10-05 Wella Aktiengesellschaft Method of skin care using a skin care preparation containing a betaine ester and an α-hydroxy acid

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
DATABASE WPI Section Ch Week 197909, Derwent World Patents Index; Class D21, AN 1979-16902B, XP002172939 *
DATABASE WPI Section Ch Week 197947, Derwent World Patents Index; Class D21, AN 1979-85000B, XP002172938 *

Also Published As

Publication number Publication date
WO2001070176A2 (de) 2001-09-27
US20030053967A1 (en) 2003-03-20
EP1267822A2 (de) 2003-01-02
DE10013578A1 (de) 2001-09-20
CN1418087A (zh) 2003-05-14
AU2001250368A1 (en) 2001-10-03
JP2003528831A (ja) 2003-09-30

Similar Documents

Publication Publication Date Title
AU2001237433A1 (en) Preparation containing quinoxaline derivatives
WO2001094381A3 (fr) Nouveaux composes de la famille des n-acylamino-amides, compositions les comprenant, et utilisations
WO2002049593A3 (de) Verwendung von dna-reparatur-enzymen als mmp-1-inhibitoren
WO2004012650A3 (fr) Compositions cosmetiques ou dermopharmaceutiques comprenant du kombucha.
EP1790238A4 (de) Aufhellende zusammensetzung mit verringertem coenzym-q-gehalt
WO2000035475A3 (de) Verfahren zur behandlung von cerebralen ischämien sowie verwendung von erythropoietin oder erythropoietin-derivaten zur behandlung von cerebralen ischämien
AU2001230202A1 (en) Formulation for protection against oxidative stress containing benzofuranone derivatives
AU1648601A (en) Cosmetics
PL373465A1 (en) Composition based on substituted 1,3-diphenylprop-2-en-1-one derivatives
WO2003003997A3 (de) Verwendung von hopfen- bzw. hopfen-malz-extrakten in kosmetischen oder dermatologischen zubereitungen
WO2001098235A3 (de) 3,4-dihydroxybenzyl-substituierte kohlensäurederivate und ihre verwendung als antioxidantien
AU4542300A (en) Aqueous cosmetic product which contains tartaric or citric acid esters of the alkyl polyglucose and an acidic active substance with preservative properties
WO2000044344A3 (de) Antioxidative hautpflegemittel
WO2004052353A3 (en) Aqueous-alcoholic depigmenting gel containing a phenolic derivative and a retinoid
DE60120689D1 (de) Verwendung einer antioxidativen zusammensetzung enthaltend einen extrakt aus mozuku-algen
WO2004041173A3 (en) Compositions for darkening the skin and/or hair
ES2186914T3 (es) Utilizacion cosmetica, dermatologica y farmaceutica de un extracto de terminalia catappa.
WO2003037288A3 (fr) Composition cosmetique mimant le sebum, et utilisations
WO2001070176A3 (de) Verwendung von 3,4-dihydroxymandelsäure zum schutz vor ultraviolettlicht-induzierten oxidativen schädigungen
WO2002069925A3 (de) VERWENDUNG VON WIRKSTOFFKOMBINATIONEN AUS α-LIPONSÄURE UND DERMATOLOGISCH VERTRÄGLICHEN SUBSTANZEN, DIE LICHTABSORPTION IM UV-A-BEREICH UND/ODER UV-B-BEREICH ZEIGEN, ZUR HERSTELLUNG VON KOSMETISCHEN ODER DERMATOLOGISCHEN ZUBEREITUNGEN
WO2001074320A3 (de) Verwendung von protease-inhibitoren in der kosmetik und pharmazie
WO2003070180A3 (en) Compositions and methods for delivery of skin cosmeceuticals
EP0706786A3 (de) Verwendung von Chlorogensäure als Antioxidans in kosmetischen, insbesondere haarkosmetischen Zubereitungen, sowie Zubereitungen, Chlorogensaüre enthaltend
WO2002072039A3 (en) Topical preparations and food preparations comprising a pyridoxine-alpha-d-glucose
PT1594456E (pt) Utilização de uma composição contendo óxido de vitamina k1 ou um seu derivado para tratamento e/ou prevenção de lesões dermatológicas em mamíferos

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

WWE Wipo information: entry into national phase

Ref document number: 2001923646

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 200206726

Country of ref document: ZA

WWE Wipo information: entry into national phase

Ref document number: IN/PCT/2002/01200/MU

Country of ref document: IN

ENP Entry into the national phase

Ref document number: 2001 568374

Country of ref document: JP

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 10221707

Country of ref document: US

WWE Wipo information: entry into national phase

Ref document number: 018068162

Country of ref document: CN

Ref document number: 2001250368

Country of ref document: AU

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWP Wipo information: published in national office

Ref document number: 2001923646

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 2001923646

Country of ref document: EP